The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 19,301–19,400 of 31,469
Lancha, A., Moncada, R., Valentí, V., Rodrı́guez, A., Catalán, V., Becerril, S., Ramírez, B., Méndez-Giménez, L., Frühbeck, G., & Gómez‐Ambrosi, J. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1240-z · Cited by 12
Insulin resistance and rheumatoid arthritis
Ferraz‐Amaro, I., Díaz‐González, F., Juanatey, C. G., & González-Gay, M. Á. (2011) · Reumatología Clínica (English Edition) · doi:10.1016/s2173-5743(11)70023-5 · Cited by 12
Nakhjavani, M., Morteza, A., Asgarani, F., Ardekani, A. M., Esteghamati, A., Khalilzadeh, O., & Rahbari, G. (2011) · Redox Report · doi:10.1179/1351000211y.0000000008 · Cited by 12
Metabolic syndrome in obese adolescents: what is enough?
SEWAYBRICKER, L. E., Antônio, M. Â. R. D. G. M., Mendes, R. T., Filho, A. D. A. B., & Zambon, M. P. (2013) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302013000100013 · Cited by 12
Putative association betweenUBE2E2polymorphisms and the risk of gestational diabetes mellitus
Kim, J. Y., Cheong, H. S., Park, B., Baik, S. H., Park, S., Kim, S., Shin, H. D., & Kim, S. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.813465 · Cited by 11
Phillips, C. M., Kearney, P. M., Carthy, V. J. C. M., Harrington, J. M., Fitzgerald, T., & Perry, I. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078950 · Cited by 12
Zhang, W., YANG, Z. K., Li, X., Wen, J., Zhang, H., Wang, S., Wang, X., Zhou, H., Fang, W., Qin, L., et al. (2014) · Gene · doi:10.1016/j.gene.2014.11.031 · Cited by 12
Kawaguchi, Y., Mizuta, T., Eguchi, Y., et al. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.0992 · Cited by 12
García-Villegas, E. A., Lerman‐Garber, I., Flores-Suárez, L. F., et al. (2014) · Medicina Clínica · doi:10.1016/j.medcli.2014.06.018 · Cited by 12
Imai, S., Naito, S., Takahashi, T., Yamauchi, A., Nakamura, E., Sato, M., Mitsuda, Y., Takagi, H., Numata, Y., Fujii, I., et al. (2014) · Analytical Biochemistry · doi:10.1016/j.ab.2014.12.003 · Cited by 12
Choudhary, P., Lonnen, K., Emery, C., Freeman, J. V., McLeod, K. M., & Heller, S. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0059 · Cited by 12
Yoshinaga, M., Sameshima, K., Tanaka, Y., et al. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0246 · Cited by 12
de Luis, D. A., Aller, R., Izaola, O., et al. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03347107 · Cited by 12
Glucagon and insulin cord blood levels in very preterm, late preterm and full-term infants
Bagnoli, F., Vodo, F., Vodo, S., et al. (2013) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0230 · Cited by 12
Síndrome metabólica em adolescentes do sexo feminino com sobrepeso e obesidade
Pinho, A. P., Brunetti, I. L., Pepato, M. T., & Nogueira‐de‐Almeida, C. A. (2012) · Revista Paulista de Pediatria · doi:10.1590/s0103-05822012000100008 · Cited by 13
Mamabolo, R. L., Alberts, M., Levitt, N. S., et al. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507742708 · Cited by 12
Santiprabhob, J., Leewanun, C., Limprayoon, K., et al. (2014) · Patient Education and Counseling · doi:10.1016/j.pec.2014.07.002 · Cited by 12
Brufani, C., Grossi, A., Fintini, D., Fiori, R., Ubertini, G., Colabianchi, D., Ciampalini, P., Tozzi, A. E., Barbetti, F., & Cappa, M. (2008) · Hormone Research in Paediatrics · doi:10.1159/000161865 · Cited by 12
Heroin Dependence Duration Influences the Metabolic Parameters
Pereska, Z., Bozinovska, C., Dimitrovski, C., Cakalarovski, K., Chibishev, A., Zdravkovska, M., Babulovska, A., & Janicevic, D. (2012) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31826bd76c · Cited by 12
Goto, M., Morita, A., Goto, A., Deura, K., Sasaki, S., Aiba, N., Shimbo, T., Terauchi, Y., Miyachi, M., Noda, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057964 · Cited by 12
Hyperhomocysteinemia, Insulin Resistance and High HS- CRP Levels in Prehypertension
Bobby, Z. (2014) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2014/8945.4669 · Cited by 12
Childhood Wrist Circumference Is Not a Predictor of Insulin Resistance in Adulthood
Watkins, A. N., Kelly, A. S., Prineas, R. J., Marlatt, K. L., Dengel, D. R., Sinaiko, A. R., Moran, A., & Steinberger, J. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.12.011 · Cited by 12
Mohteshamzadeh, M., Wong, C., Whiticar, R., & Thomas, S. (2008) · American Journal of Nephrology · doi:10.1159/000151490 · Cited by 12
Anan, F., Masaki, T., Umeno, Y., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0388 · Cited by 12
Walsh, J., Mahony, R. M., Canty, G., Foley, M. E., & McAuliffe, F. M. (2014) · British Journal Of Nutrition · doi:10.1017/s000711451400110x · Cited by 12
de Luis, D. A., Aller, R., Sagrado, M. G., et al. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.001 · Cited by 12
Danziger, J., Biggs, M. L., Niemi, M. A., Ix, J. H., Kizer, J. R., Djoussé, L., de Boer, I. H., Siscovick, D. S., Kestenbaum, B. R., & Mukamal, K. J. (2013) · Metabolism · doi:10.1016/j.metabol.2013.07.008 · Cited by 12
Wu, C., Lin, J. D., Li, J.-C., Hsiao, F., Hsieh, C. H., Kuo, S. W., Hung, Y. J., Lu, C.-H., He, C., & Pei, D. (2008) · PubMed · Cited by 12
Schreuder, T. H. A., Duncker, D. J., Hopman, M. T. E., & Thijssen, D. H. J. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.081182 · Cited by 11
Pereira, I. D. S., Pontes, T., Vieira, R. A. L., Folly, G. A. D. F., Silva, F. C. D. S., de Oliveira, F. P. D., Amaral, J. F., de Freitas, R. N., & Volp, A. C. P. (2015) · Nutrición Hospitalaria · doi:10.3305/nh.2015.32.2.9135 · Cited by 7
Al-Hakeim, H., & Ali, M. M. (2012) · Journal of Diabetology · doi:10.4103/2078-7685.198026 · Cited by 12
Role of omentin-1 and C-reactive protein in obese subjects with subclinical inflammation
Alissa, E. M., Al-Salmi, M. M., Alama, N., & Ferns, G. A. (2015) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2015.12.001 · Cited by 12
Insenser, M. R., Montes‐Nieto, R., Martínez-García, M. Á., & Escobar-Morreale, H. F. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0912 · Cited by 9
Intermittent hypoxia maintains glycemia in streptozotocin-induced diabetic rats
Chen, X., Zhao, T., Huang, X., Wu, L., Wu, K., Fan, M., & Zhu, L. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0679-3 · Cited by 12
Rosuvastatin vs. protease inhibitor switching for hypercholesterolaemia: a randomized trial
Lee, F., Monteiro, P. F., Baker, D. A., Bloch, M. T., Roth, N., Finlayson, R. J., Moore, R. J., Hoy, J., Martínez, E., & Carr, A. D. (2016) · HIV Medicine · doi:10.1111/hiv.12362 · Cited by 12
Immune Phenotypes of Endothelial-Derived Microparticles in Dysmetabolic Patients.
Berezin, A. Е. (2015) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000353 · Cited by 12
Xiang, H., Yang, C., Xiang, T., Wang, Z., Ge, X., Li, F., Su, Y., Chen, H., Huang, X., & Zeng, Q. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0144 · Cited by 12
Frequency of metabolic syndrome in type 2 diabetes and its relationship with insulin resistance.
Ahmed, S., Ahmed, S. A., & Ali, N. (2010) · PubMed · Cited by 11
Uemura, H., Katsuura‐Kamano, S., Yamaguchi, M., Nakamoto, M., Hiyoshi, M., & Arisawa, K. (2013) · PubMed · doi:10.3275/9066 · Cited by 13
Lejsková, M., Pitha, J. V., Adámková, S., Auzký, O., Adámek, T., Babková, E., Lánská, V., & Alusik, S. (2014) · Physiological Research · doi:10.33549/physiolres.932878 · Cited by 13
Metabolic syndrome in adolescents: definition based on regression of IDF adult cut-off points
Benmohammed, K., Valensi, P. E., Balkau, B., & Lezzar, A. (2016) · Public Health · doi:10.1016/j.puhe.2016.09.001 · Cited by 12
Lin, P., & Borer, K. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165378 · Cited by 13
Martínez-Cerón, E., Barquiel, B., Am, B., Casitas, R., Galera, R., García-Benito, C., Hernánz, Á., Alonso‐Fernández, A., & Rio, F. G. (2016) · American Journal of Respiratory and Critical Care Medicine · Cited by 12
Hwang, Y., Fujimoto, W. Y., Kahn, S. E., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001296 · Cited by 12
Zhang, W., YANG, Z. K., Niu, Y., Li, X., Zhu, L., Lü, S., Zhang, H., Fan, J., Ning, G., Qin, L., et al. (2017) · BMC Endocrine Disorders · doi:10.1186/s12902-017-0176-4 · Cited by 15
Park, B. H., Yoon, J. M., Kim, J. H., et al. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.4.756 · Cited by 12
Kälble, F., Seckinger, J., Schaier, M., et al. (2017) · Clinical Transplantation · doi:10.1111/ctr.13024 · Cited by 12
Genetic aetiology of glycaemic traits: approaches and insights
Wheeler, E., Marenne, G., & Barroso, I. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx293 · Cited by 13
Functional correlates of detailed body composition in healthy elderly subjects
Geisler, C., Schweitzer, L., & Müller, M. J. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00162.2017 · Cited by 13
Effects of vitamin D supplementation on carotid intima-media thickness in HIV-infected youth
Eckard, A. R., Raggi, P., O’Riordan, M. A., Rosebush, J., Labbato, D. E., Chahroudi, A., Ruff, J. H., Longenecker, C. T., Tangpricha, V., & McComsey, G. A. (2017) · Virulence · doi:10.1080/21505594.2017.1365217 · Cited by 11
Piña-Aguero, M. I., Zaldivar-Delgado, A., Salas-Fernández, A., Martínez-Basila, A., Bernabé-García, M., & Maldonado‐Hernández, J. (2017) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.4873 · Cited by 12
Lee, I., Chen, C., Wang, J., Fu, C., Lee, W., Liang, K., Lin, S., & Sheu, W. H. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.10.023 · Cited by 12
Hitsumoto, T. (2018) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3364w · Cited by 12
groups, O. B. O. T. Y. A. S.-D. S., Tabesh, M., Callegari, E. T., Gorelik, A., Garland, S. M., Nankervis, A. J., Subasinghe, A. K., & Wark, J. D. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0086-1 · Cited by 12
Lindsay, K. L., Brennan, L., Kennelly, M. A., Curran, S., Coffey, M., Smith, T. P., Foley, M. E., Hatunic, M., & McAuliffe, F. M. (2018) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-018-1744-y · Cited by 12
Association of serum ferritin with insulin resistance in offsprings of type 2 diabetics
Khalil, O. A., Seliem, F. O., Alnahal, A., Awad, M. M., Sadek, A. M. E. M., & Fawzy, M. S. (2018) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_70_17 · Cited by 12
Simões, N. F., Domingos, A. L. G., de Oliveira, F. L. P., Caldas, I. S., Guedes, M. R., Fajardo, V. C., & de Freitas, S. N. (2018) · Nutrire · doi:10.1186/s41110-018-0060-7 · Cited by 12
Poon, A. K., Meyer, M. L., Reaven, G. M., Knowles, J. W., Selvin, E., Pankow, J. S., Couper, D. J., Loehr, L. R., & HEISS, G. M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02437 · Cited by 13
Mohamed, R. A., Galal, O., Mohammed, A. R., & El-Abhar, H. S. (2018) · RSC Advances · doi:10.1039/c7ra13105d · Cited by 11
Yfanti, C., Τσιόκανος, Α., Fatouros, I. G., Theodorou, A. A., Deli, C. K., Koutedakis, Y., & Jamurtas, A. Z. (2017) · PubMed Central · Cited by 13
Fiorentino, T. V., Succurro, E., Arturi, F., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32108-8 · Cited by 12
Yari, Z., Rahimlou, M., Poustchi, H., & Hekmatdoost, A. (2019) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000565 · Cited by 12
Lu, C., Li, Z., Yang, J., Feng, L., Wang, C., & Shi, Q. (2019) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2019.05.002 · Cited by 12
Hyperinsulinemia and thyroid peroxidase antibody in Chinese patients with papillary thyroid cancer
Guo, X., Chen, X., Zhang, C., et al. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0358 · Cited by 12
Kindler, J. M., Laing, E. M., Liu, W., Dain, J. A., & Lewis, R. D. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3727 · Cited by 12
Hasegawa, R., Iwase, I., Takagi, T., Kondo, M., Matsui, M., & KAWASHIMA, C. (2019) · Animal Science Journal · doi:10.1111/asj.13300 · Cited by 12
Davidson, F., Matsha, T. E., Erasmus, R. T., et al. (2019) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2019-028 · Cited by 12
Falkowski, B., Duda‐Sobczak, A., Araszkiewicz, A., Chudziński, M., Urbas, M., Gajewska, E., Borucki, Ł., & Zozulińska‐Ziółkiewicz, D. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3307 · Cited by 12
Serra, M. C., Ryan, A. S., Hafer‐Macko, C. E., Yepes, M., Nahab, F. B., & Ziegler, T. R. (2020) · Nutrients · doi:10.3390/nu12030701 · Cited by 12
Bos, M. M., Noordam, R., Bennett, K., Beekman, M., Mook-Kanamori, D. O., van Dijk, K. W., Slagboom, P. E., Lundstedt, T., Surowiec, I., & van Heemst, D. (2020) · Metabolomics · doi:10.1007/s11306-020-01653-7 · Cited by 12
Ramzan, F., D’Souza, R. F., Durainayagam, B. R., Milan, A. M., Roy, N. C., Kruger, M. C., Henry, C. J., Mitchell, C. J., & Cameron‐Smith, D. (2020) · Genes & Nutrition · doi:10.1186/s12263-020-0660-8 · Cited by 12
Kitagawa, A., Ohta, Y., OHASHI, K., Yashiro, K., & FUKUZAWA, K. (2020) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.66.200 · Cited by 12
Serum visfatin concentration and its relationship with sex hormones in obese Saudi women.
Alnowihi, S. M., Doghaither, H. A. A., & Osman, N. N. (2020) · PubMed Central · Cited by 12
Sharif, E., Alwakeel, M., Mohamed, A., Kerkadi, A., & Rizk, N. M. (2020) · Genes · doi:10.3390/genes11070814 · Cited by 12
Song, Y., & Lee, K. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.07.036 · Cited by 12
Ghalandari, K., Shabani, M., Khajehlandi, A., & Mohammadi, A. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1797104 · Cited by 12
Kusakabe, T., Yokota, S., Shimizu, M., Inoue, T., Tanaka, M., Ohue‐Kitano, R., Muranaka, K., Yamakage, H., Wada, H., Hasegawa, K., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001303 · Cited by 11
Wang, X., Feng, H., Fan, D.-H., Zou, G., Han, Y., & Liu, L. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102583 · Cited by 12
Lass, N., Barth, A. C. R., & Reinehr, T. (2020) · Hormone Research in Paediatrics · doi:10.1159/000509786 · Cited by 14
Yuzbashian, E., Asghari, G., Chan, C. B., Hedayati, M., Safarian, M., Zarkesh, M., Mirmiran, P., & Khalaj, A. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02422-x · Cited by 12
Benhalima, K., Landtsheer, A. D., Crombrugge, P. V., Moyson, C., Verhaeghe, J., Verlaenen, H., Vercammen, C., Maes, T., Dufraimont, E., Block, C. E. M. D., et al. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01619-0 · Cited by 12
Song, S. O., Han, S. J., Kahn, S. E., et al. (2020) · Obesity · doi:10.1002/oby.23035 · Cited by 12
Shi, J., Wang, Z., Zhang, W., Niu, Y., Lin, N., Li, X., Zhang, H., Ning, G., Fan, J., Qin, L., et al. (2021) · Nutrition & Metabolism · doi:10.1186/s12986-021-00562-3 · Cited by 12
Cho, E.-A., Lee, N. H., Ahn, J. H., et al. (2020) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2020.12.002 · Cited by 12
Kliewer, W. L., & Robins, J. L. W. (2021) · International Journal of Behavioral Medicine · doi:10.1007/s12529-021-09978-w · Cited by 13
Comparative effects of metformin and glibenclamide on the redox balance in type 2 diabetic patients
Almulathanon, A. A. Y., Mohammad, J. A., & Fathi, F. H. (2021) · Pharmacia · doi:10.3897/pharmacia.68.e63365 · Cited by 12
Domouzoglou, E. M., Vlahos, A. P., Cholevas, V., Papafaklis, M. I., Chaliasos, N., Siomou, E. C., Michalis, L. K., Tsatsoulis, A. A., & Naka, K. Κ. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040258.129 · Cited by 12
LEAP‐2/ghrelin interplay in adult growth hormone deficiency: Cause or consequence? A pilot study
Vergani, E., Bruno, C., Gavotti, C., Aversa, L. S., Martire, M. S., Mancini, A., & Currò, D. (2021) · IUBMB Life · doi:10.1002/iub.2504 · Cited by 11
Brown Adipose Tissue, Adiposity, and Metabolic Profile in Preschool Children
Tint, M. T., Michael, N., Sadananthan, S. A., Huang, J. Y., Khoo, C. M., Godfrey, K. M., Shek, L. P., Lek, N., Tan, K. H., Yap, F. K. P., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab447 · Cited by 12
Tan, Y. C. R. S., Tang, X., Mu, P., Yang, Y., Li, M., Nie, Y., Li, H., Zhu, Y., & Chen, Y. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s313224 · Cited by 12
Khatiwada, S., Lecomte, V., Fenech, M. F., Morris, M. J., & Maloney, C. (2021) · Cells · doi:10.3390/cells10071751 · Cited by 14
Yahya, R., Jainandunsing, S., Rashid, M., van der Zee, L., Touw, A., de Rooij, F. W. M., Sijbrands, E. J. G., Verhoeven, A. J. M., & Mulder, M. T. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.107993 · Cited by 12
Rodríguez-López, L. A., Torre-Villalvazo, I., Alemán, G., Flores‐López, A., Guevara‐Cruz, M., Sánchez‐Tapia, M., Torre-Anaya, E. A., Martínez-López, V., Vásquez‐Reyes, S., Torres‐Villalobos, G., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00921-3 · Cited by 12
Skeletal Muscle Microvascular Dysfunction Manifests Early in Diabetic Cardiomyopathy
Loai, S., Zhou, Y., Vollett, K. D. W., & Cheng, H. M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.715400 · Cited by 12
Noghani, S. N., Milani, N., Afkhamizadeh, M., et al. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.294 · Cited by 12
Fragoso-Bargas, N., Opsahl, J. O., Kiryushchenko, N., Böttcher, Y., Lee-Ødegård, S., Qvigstad, E., Richardsen, K. R., Waage, C. W., Sletner, L., Jenum, A. K., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256158 · Cited by 11
Type 2 Diabetes Modifies Skeletal Muscle Gene Expression Response to Gastric Bypass Surgery
Barberio, M. D., Dohm, G. L., Pories, W. J., Gadaleta, N. A., Houmard, J. A., Nadler, E. P., & Hubal, M. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.728593 · Cited by 12
Arcidiacono, D., Zaramella, A., Fabris, F., Sánchez‐Rodríguez, R., Nucci, D., Fassan, M., Nardi, M., Benna, C., Cristofori, C., Morbin, T., et al. (2021) · Nutrients · doi:10.3390/nu13103638 · Cited by 12
Stojnić, B., Serrano, A., Sušak, L., Palou, A., Bonet, M. L., & Ribot, J. (2021) · Nutrients · doi:10.3390/nu13103607 · Cited by 11
Kim, S., Park, J. H., Oh, Y. H., Kim, H. J., Kong, M. H., & Moon, J. H. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048309 · Cited by 14
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
